Patents by Inventor Ladan PARHAMIFAR

Ladan PARHAMIFAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDIC BLOCKS FOR NUCLEIC ACID DELIVERY
    Publication number: 20240131174
    Abstract: A polypeptide conjugate for use in a method for binding and/or internalization of the polypeptide conjugate to a mammalian cell having a transferrin receptor (TFRC) and/or receptor for advanced glycation end products (RAGE). The polypeptide conjugate may be used in a method for targeting of a drug delivery system or diagnostic delivery system.
    Type: Application
    Filed: August 18, 2023
    Publication date: April 25, 2024
    Inventors: Seyed Moien MOGHIMI, Linping WU, Davoud AHMADVAND, Ladan PARHAMIFAR
  • Peptidic blocks for nucleic acid delivery
    Patent number: 11730820
    Abstract: A polypeptide conjugate for use in a method for binding and/or internalization of the polypeptide conjugate to a mammalian cell having a transferrin receptor (TFRC) and/or receptor for advanced glycation end products (RAGE). The polypeptide conjugate may be used in a method for targeting of a drug delivery system or diagnostic delivery system.
    Type: Grant
    Filed: April 2, 2021
    Date of Patent: August 22, 2023
    Assignee: S. M. Discovery Group Inc.
    Inventors: Seyed Moien Moghimi, Linping Wu, Davoud Ahmadvand, Ladan Parhamifar
  • IMMUNE STIMULATING MICELLE COMPOSITION
    Publication number: 20220354789
    Abstract: The present invention relates to immune stimulating micelle compositions, and their use in treatment of diseases and disorders, such as cancer. In particular, the present invention relates to micelle compositions comprising a TLR7 agonist, such as 1V270.
    Type: Application
    Filed: September 18, 2020
    Publication date: November 10, 2022
    Inventors: Jonas Rosager Henriksen, Thomas Lars Andresen, Simon Skjøde Jensen, Ladan Parhamifar, Rasmus Dithmar Münter, Anders E. Hansen, Camilla Stavnsbjerg, Esben Christensen
  • PEPTIDIC BLOCKS FOR NUCLEIC ACID DELIVERY
    Publication number: 20210290773
    Abstract: A polypeptide conjugate for use in a method for binding and/or internalization of the polypeptide conjugate to a mammalian cell having a transferrin receptor (TFRC) and/or receptor for advanced glycation end products (RAGE). The polypeptide conjugate may be used in a method for targeting of a drug delivery system or diagnostic delivery system.
    Type: Application
    Filed: April 2, 2021
    Publication date: September 23, 2021
    Applicant: S. M. Discovery Group Inc.
    Inventors: Seyed Moien MOGHIMI, Linping Wu, Davoud Ahmadvand, Ladan Parhamifar
  • Peptidic self-assembly for nucleic acid delivery
    Patent number: 11000599
    Abstract: A polypeptide conjugate for use in a method for binding and/or internalization of the polypeptide conjugate to a mammalian cell having a transferrin receptor (TFRC) and/or receptor for advanced glycation end products (RAGE). The polypeptide conjugate may be used in a method for targeting of a drug delivery system or diagnostic delivery system.
    Type: Grant
    Filed: May 29, 2018
    Date of Patent: May 11, 2021
    Assignee: S. M. Discovery Group Inc.
    Inventors: Seyed Moien Moghimi, Linping Wu, Davoud Ahmadvand, Ladan Parhamifar
  • CATIONIC LIPOSOMES
    Publication number: 20200163880
    Abstract: Disclosed herein are cationic liposomes suitable for specific delivery of immunomodulating agents to monocytes and dendritic cells. The cationic liposomes comprise phospholipids, cholesterol, cationic lipids, PEG and at least one active ingredient and have a zeta potential in the range of 13-25 mV. Further disclosed are uses of such cationic liposomes in various pharmaceutical applications.
    Type: Application
    Filed: July 13, 2018
    Publication date: May 28, 2020
    Inventors: Thomas Lars ANDRESEN, Simon Skjøde JENSEN, Jonas Rosager HENRIKSEN, Ladan PARHAMIFAR, Rasmus Mikkel Münter LASSEN
  • PEPTIDIC SELF-ASSEMBLY FOR NUCLEIC ACID DELIVERY
    Publication number: 20200069813
    Abstract: A polypeptide conjugate for use in a method for binding and/or internalization of the polypeptide conjugate to a mammalian cell having a transferrin receptor (TFRC) and/or receptor for advanced glycation end products (RAGE). The polypeptide conjugate may be used in a method for targeting of a drug delivery system or diagnostic delivery system.
    Type: Application
    Filed: May 29, 2018
    Publication date: March 5, 2020
    Inventors: Seyed Moien MOGHIMI, Linping WU, Davoud AHMADVAND, Ladan PARHAMIFAR